ReviewInternational journal of transgender health2026
Worldwide prevalence of anxiety in transgender persons: Systematic review with meta-analysis.
Review in International journal of transgender health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: This systematic review and meta-analysis estimate the global pooled prevalence of anxiety among transgender individuals. Methods: A comprehensive search was conducted in Scopus, Web of Science, Embase, EBSCOhost, VHL, PsycINFO, and PubMed. Observational studies reporting anxiety prevalence in transgender people were included. Meta-analytical methods were applied using a random-effects model to compute pooled prevalence estimates. Heterogeneity, publication bias, and subgroup analyses were assessed. Results: A total of 71 studies, comprising 73,565 transgender individuals from 23 countries, were included. The global pooled prevalence of anxiety was 43% (95% CI: 38-48%), with higher rates among non-binary individuals (59%) compared to transmasculine (44%) and transfeminine (37%) identities. Significant variability was observed across geographic regions, age groups, ethnicity/race of the samples, and assessment methods. Non-probabilistic sampling and self-reported measures were associated with higher prevalence estimates. Conclusion: Transgender individuals experience a disproportionately high prevalence of anxiety, with notable disparities by gender identity and region. Findings emphasize the need for targeted mental health interventions and inclusive healthcare policies. Standardized methodologies and broader geographical and ethnical representation in future research are essential to enhance global understanding and inform policy development.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.